HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhiliang Jia Selected Research

mithramycin A

8/2011Combining betulinic acid and mithramycin a effectively suppresses pancreatic cancer by inhibiting proliferation, invasion, and angiogenesis.
2/2010Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activity.
7/2008Targeted inhibition of Sp1-mediated transcription for antiangiogenic therapy of metastatic human gastric cancer in orthotopic nude mouse models.
12/2007Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer.
5/2007Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin A.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhiliang Jia Research Topics

Disease

34Neoplasms (Cancer)
01/2024 - 01/2006
18Pancreatic Neoplasms (Pancreatic Cancer)
10/2020 - 05/2007
14Neoplasm Metastasis (Metastasis)
01/2024 - 01/2006
8Carcinogenesis
01/2019 - 04/2009
6Lymphatic Metastasis
07/2013 - 01/2006
5Stomach Neoplasms (Stomach Cancer)
04/2009 - 01/2006
2Osteosarcoma (Osteogenic Sarcoma)
01/2024 - 01/2022
2Hepatocellular Carcinoma (Hepatoma)
01/2016 - 09/2012
2Colonic Neoplasms (Colon Cancer)
01/2013 - 11/2008
1Glioblastoma (Glioblastoma Multiforme)
10/2023
1Cytokine Release Syndrome
01/2022
1Hematologic Neoplasms (Hematological Malignancy)
01/2022
1Glioma (Gliomas)
01/2019
1Hypoxia (Hypoxemia)
12/2017
1Leukemia
02/2017
1Adenocarcinoma
08/2014
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
08/2014
1Pancreatitis
07/2013
1Intestinal Neoplasms (Intestinal Cancer)
01/2013
1Neuroendocrine Tumors (Neuroendocrine Tumor)
04/2007
1Carcinoid Tumor (Carcinoid)
04/2007

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
10/2020 - 01/2006
9Transcription Factors (Transcription Factor)IBA
12/2017 - 06/2008
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2009 - 11/2006
5mithramycin AIBA
08/2011 - 05/2007
4Messenger RNA (mRNA)IBA
10/2020 - 11/2008
3Interleukin-12 (IL 12)IBA
01/2024 - 01/2022
3RNA (Ribonucleic Acid)IBA
01/2024 - 06/2008
3CateninsIBA
01/2019 - 08/2014
3Forkhead Transcription Factors (Forkhead Box Proteins)IBA
05/2014 - 02/2012
3Small Interfering RNA (siRNA)IBA
01/2013 - 12/2007
3Bevacizumab (Avastin)FDA Link
07/2008 - 04/2007
3Sp1 Transcription FactorIBA
07/2008 - 11/2006
2Chimeric Antigen ReceptorsIBA
01/2024 - 01/2022
2CytokinesIBA
01/2022 - 07/2013
2Neurofibromin 2 (Merlin)IBA
11/2015 - 11/2015
2Forkhead Box Protein M1IBA
02/2015 - 01/2013
2Calcitriol Receptors (Calcitriol Receptor)IBA
02/2015 - 09/2012
2Vitamin DFDA LinkGeneric
02/2015 - 09/2012
2Betulinic AcidIBA
09/2013 - 08/2011
2Protein Isoforms (Isoforms)IBA
07/2013 - 12/2010
2Kruppel-Like Factor 4IBA
09/2012 - 06/2008
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
12/2010 - 11/2008
2Neutralizing AntibodiesIBA
07/2008 - 05/2007
2ErbB Receptors (EGF Receptor)IBA
12/2007 - 05/2007
1LigandsIBA
01/2024
1VimentinIBA
01/2024
1Transforming Growth Factor beta (TGF-beta)IBA
01/2024
1Single-Chain AntibodiesIBA
10/2023
1ChemokinesIBA
10/2023
1Fibrinogen (Factor I)FDA Link
10/2023
1Arginine (L-Arginine)FDA Link
10/2020
1Enhancer of Zeste Homolog 2 ProteinIBA
01/2019
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
12/2017
13,3'-diindolylmethane (diindolylmethane)IBA
09/2017
1MethyltransferasesIBA
09/2017
1Differentiation AntigensIBA
09/2017
1DNA (Deoxyribonucleic Acid)IBA
09/2017
1Oncogene Proteins (Oncogene Protein)IBA
02/2017
1Cadherins (E-Cadherin)IBA
01/2017
1Tetracycline (Achromycin)FDA LinkGeneric
01/2016
1TeaIBA
11/2015
1seocalcitolIBA
02/2015
1Calcitriol (Calcijex)FDA LinkGeneric
02/2015
1Lactate Dehydrogenase 5IBA
08/2014
1EnzymesIBA
05/2014
1Lamin Type B (Lamin B)IBA
09/2013
1Complementary DNA (cDNA)IBA
09/2013
1CeramidesIBA
07/2013
1SphingolipidsIBA
07/2013
1Interleukin-6 (Interleukin 6)IBA
07/2013
1Interleukin-8 (Interleukin 8)IBA
07/2013
1LipidsIBA
07/2013
1Chemokine CXCL10IBA
07/2013
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2013
1Epidermal Growth Factor (EGF)IBA
07/2013
1Urokinase Plasminogen Activator ReceptorsIBA
01/2013
1villinIBA
03/2012
1Methylnitrosourea (N-Methyl-N-nitrosourea)IBA
03/2012
1Caveolin 1IBA
02/2012
1GemcitabineFDA Link
08/2011
1tolfenamic acidIBA
02/2010
1enhanced green fluorescent proteinIBA
01/2010
1MethylcholanthreneIBA
01/2010
1TOR Serine-Threonine KinasesIBA
03/2009
1Transcription Factor 3IBA
11/2008
1Platelet-Derived Growth FactorIBA
12/2007
1Monoclonal AntibodiesIBA
04/2007
1Oxygen (Dioxygen)IBA
01/2006
1Endoplasmic Reticulum Chaperone BiPIBA
01/2006
1Glucose (Dextrose)FDA LinkGeneric
01/2006

Therapy/Procedure

11Therapeutics
01/2024 - 11/2006
1Immunotherapy
01/2024
1Liver Transplantation
01/2016
1Intraperitoneal Injections
12/2007